R&G PharmaStudies Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
David Wu
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | less than a year |
Recent management updates
CEO
David Wu (63 yo)
no data
Tenure
Mr. Wu Jie, also known as David, MBA serves as Chairman and General manager of R&G PharmaStudies Co., Ltd. He served as General Manager and Director of Tianfa Petroleum Co., Ltd.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Deputy GM & Director | no data | CN¥822.90k | no data | |
| Chairman & GM | no data | no data | no data | |
| COO, Senior VP & Director | no data | no data | 0.75% CN¥ 29.4m | |
| Senior VP | no data | no data | no data | |
| Independent Director | less than a year | no data | no data | |
| Director | no data | no data | 12.23% CN¥ 479.8m | |
| Supervisor | no data | no data | 0.072% CN¥ 2.8m | |
| Supervisory Board Chairman | no data | no data | 0.12% CN¥ 4.7m | |
| Supervisor | no data | no data | 0.027% CN¥ 1.1m | |
| Director | no data | no data | no data | |
| Independent Director | less than a year | no data | no data | |
| Independent Director | less than a year | no data | no data |
0.3yrs
Average Tenure
55yo
Average Age
Experienced Board: 301333's board of directors are not considered experienced ( 0.3 years average tenure), which suggests a new board.